MGC Diagnostics (MGCD) Swings to Q4 Loss
Tweet
Share
E-mailGet Alerts MGCD Hot Sheet
Join SI Premium – FREE
MGC Diagnostics (NASDAQ: MGCD) reported Q4 EPS of ($0.07), versus $0.20 reported last year. Revenue for the quarter came in at $9.7 million, versus $9.14 million reported last year.
For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- SeaStar Medical (ICU) Misses Q1 EPS by 4c
- Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
